Announcement on Appointment of Senior Management Members
Filed with SSE · · 2 pages · Chinese
Earlier from Sinotherapeutics
- Announcement on Postponement of Investment Projects Financed by Raised Funds
- Announcement on Voluntary Disclosure of the Renewal and Inclusion of the Company’s Product in the National Medical Insurance Catalog
- Announcement on Attending Three-Quarter Report Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2025
- Report for Q3 2025
- Announcement on Voluntary Disclosure of the Proposed Selection of Products in the National Centralized Drug Procurement
Later from Sinotherapeutics
- Announcement on Voluntary Disclosure of Clinical Trial Applications for Eisaiconazole Sulfate for Injection Approved by China NMPA
- Summary Announcement on 2025 Restricted Stock Incentive Plan (Revised Draft)
- Announcement on Provision for Asset Impairment for 2025
- Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
- Announcement on Voluntary Disclosure of the Proposed Selection of Products in the National Continuation Drug Procurement
Follow Sinotherapeutics into a list and get an email when it puts out news.
Follow Sinotherapeutics